CFTC chair backs prediction markets as a tool for managing medical costs
CFTC chair Michael Selig said prediction markets could help people with medical conditions manage financial risks associated with future treatment costs. He cited trading on the likelihood of a drug passing a trial as an example. The CFTC has opened a public comment period on proposed prediction-market rules, and Selig said the agency would assert its jurisdiction over the markets.
Selig’s comments indicate the CFTC intends to assert jurisdiction over prediction markets, including drug-trial contracts.